Resistance Analysis and Characterization of a Thiazole Analogue, BP008, as a Potent Hepatitis C Virus NS5A Inhibitor

Hepatitis C virus (HCV) is a global health problem, affecting approximately 3% of the world's population. The standard treatment for HCV infection is often poorly tolerated and ineffective. Therefore, the development of novel or more effective treatment strategies to treat chronic HCV infection...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lin, Hui-Mei, Wang, Jing-Chyi, Hu, Han-Shu, Wu, Pei-Shan, Yang, Chi-Chen, Wu, Chung-Pu, Pu, Szu-Yuan, Hsu, Tsu-An, Jiaang, Weir-Torn, Chao, Yu-Sheng, Chern, Jyh-Haur, Yeh, Teng-Kuang, Yueh, Andrew
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2012
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3256078/
https://ncbi.nlm.nih.gov/pubmed/22006008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00599-11
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi